Virtual Medicinal Product (VMP)
-
Mifamurtide 4mg powder for dispersion for infusion vials
Name Details
Mifamurtide 4mg powder for dispersion for infusion vials
|
20-08-2024
|
|
Mifamurtide 4mg powder for suspension for infusion vials
|
17-02-2010
|
19-08-2024
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Powder for dispersion for infusion
- Ontology Form/Route
- dispersioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L03AX15
SNOMED Codes
Code
|
Start Date
|
End Date
|
16698811000001101 |
17-02-2010 |
|
VMP Ingredients
VMP ingredients table
Mifamurtide |
Based on Ingredient Substance |
|
4 mg |
|
Name
Mifamurtide
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
4.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Mifamurtide
-
VMP
(Current) Mifamurtide 4mg powder for dispersio...
Virtual Medicinal Product Pack (VMPP) Information